DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 13 May · 12:57 IST

Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹1267.50
prior close
₹1262.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.4+0.3+0.6+2.7+6.0+5.0+5.2+4.2+3.4+0.1+0.9-2.4
Up moveDown movePending
AI summary

Dr. Reddy's Laboratories has informed the stock exchanges about the publication of its audited financial results for Q4 FY2026 and the full year ended March 31, 2026. The results were published in Business Standard and Andhra Prabha newspapers on May 13, 2026, as per SEBI listing regulations. The Board of Directors had approved these results at their meeting held on May 12, 2026, based on the Audit Committee's recommendations. The detailed financial statements are available on the company's website via a QR code link.

Likely market impact

This is a routine regulatory compliance filing confirming that Q4 and FY2026 financial results have been publicly disclosed. The actual financial performance numbers are not detailed in this notification—investors should refer to the full results available on the company website or official exchange filings for specific revenue, profit, and other key metrics.